Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
it
en
04 November 2019
ALANTRA research 04/02/2019
04 November 2019
CFO SIM – PHARMANUTRA 2017 FY RESULT RELEASE 19/04/2018
31 October 2019
Internal Dealing 08/10/2018 ROBERTO LACORTE
31 October 2019
Internal Dealing 09/10/2018 ANDREA LACORTE
31 October 2019
REPORT ON THE 2017 FINANCIAL STATEMENTS AND CONSOLIDATED FINANCIAL STATEMENTS
31 October 2019
REPORT OF THE BOARD OF STATUTORY AUDITORS ON THE FINANCIAL STATEMENTS AT 31/12/2017
31 October 2019
Relazione illustrativa nomina Amministratore
31 October 2019
REPORT ON THE 31/12/2017 FINANCIAL STATEMENTS
31 October 2019
Report of the Board of Statutory Auditors on 2017 Pharmanutra Financial Statement
31 October 2019
Statutory financial statements 31/12/2017
31 October 2019
Modello delega per intervento assemblea aprile Pharmanutra
31 October 2019
Consolidated financial statements 31/12/2017
1
2
…
11
>